Document is current
Any future updates will be listed below
-
Authors
Wang, Hui
Eiber, Matthias
Langbein, Thomas
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG Sonderforschungsbereich 824, project B11)
Blue Earth Diagnostics (licensee for rhPSMA)
- License Information
-
More Information
Article History
Received: 30 December 2019
Accepted: 3 March 2020
First Online: 16 April 2020
Compliance with ethical standards
:
: Matthias Eiber is named as an inventor on a patent application for rhPSMA. Matthias Eiber is a consultant for Blue Earth Diagnostics. No other potential conflict of interest relevant to this article was reported.
: All procedures performed in studies involving patients were in accordance with the ethical standards of the institutional research committee and with the Helsinki declaration.
: During our research, informed consent for each patient was obtained as patient privacy rights and they were always observed. Written informed consent was obtained from the patient.
: Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient.
